Table 1.
Question | Therapy |
---|---|
1 | Should patients with SSc-ILD be treated with cyclophosphamide? |
2 | Should patients with SSc-ILD be treated with mycophenolate? |
3 | Should patients with SSc-ILD be treated with rituximab? |
4 | Should patients with SSc-ILD be treated with tocilizumab? |
5 | Should patients with SSc-ILD be treated with nintedanib? |
6 | Should patients with SSc-ILD be treated with nintedanib plus mycophenolate? |
7 | Should patients with SSc-ILD be treated with pirfenidone? |
8 | Should patients with SSc-ILD be treated with pirfenidone plus mycophenolate? |
Definition of abbreviation: PICO = population, intervention, comparison, outcome; SSc-ILD = systemic sclerosis–associated interstitial lung disease.